|
VMA21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.924200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.775600E-01 |
| Normal-vs-Stage2 |
5.992200E-01 |
| Normal-vs-Stage3 |
5.182800E-01 |
| Normal-vs-Stage4 |
6.021200E-01 |
| Stage1-vs-Stage2 |
6.422800E-01 |
| Stage1-vs-Stage3 |
5.502200E-01 |
| Stage1-vs-Stage4 |
6.488000E-01 |
| Stage2-vs-Stage3 |
9.805400E-01 |
| Stage2-vs-Stage4 |
9.077600E-01 |
| Stage3-vs-Stage4 |
9.164800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.796200E-01 |
| Normal-vs-AfricanAmerican |
3.491500E-02 |
| Normal-vs-Asian |
6.512400E-01 |
| Caucasian-vs-AfricanAmerican |
3.003900E-02 |
| Caucasian-vs-Asian |
6.878200E-01 |
| AfricanAmerican-vs-Asian |
1.802020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.913000E-01 |
| Normal-vs-Female |
7.069400E-01 |
| Male-vs-Female |
8.919600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.512000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.298400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.522000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.668500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.482800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.380400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.379600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.720000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.397800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.094200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.413200E-01 |
| Normal-vs-Grade 2 |
3.843400E-01 |
| Normal-vs-Grade 3 |
1.288600E-01 |
| Normal-vs-Grade 4 |
1.114970E-01 |
| Grade 1-vs-Grade 2 |
7.310200E-01 |
| Grade 1-vs-Grade 3 |
3.385800E-01 |
| Grade 1-vs-Grade 4 |
1.667050E-01 |
| Grade 2-vs-Grade 3 |
7.259200E-03 |
| Grade 2-vs-Grade 4 |
2.937800E-02 |
| Grade 3-vs-Grade 4 |
5.367000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.480800E-01 |
| Normal-vs-ccB subtype |
6.324600E-01 |
| ccA subtype-vs-ccB subtype |
1.518430E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.013600E-01 |
| Normal-vs-N1 |
7.878000E-01 |
| N0-vs-N1 |
8.349600E-01 |
|
|
